Abstract
This retrospective analysis explored the relationship between the timing of antidepressant use and long-term functional status after stroke. We used linked health administrative data from a cohort of adult stroke patients in New Zealand. Demographics and prescription information were obtained from the National Minimum Dataset and Pharmaceutical Collection. Activities of Daily Living (ADL) scores for the same patients were obtained from the International Resident Assessment Instrument (interRAI). Beta regression investigated any relationship between antidepressant exposure and functional status. Of 3509 patients with an ischaemic stroke, 31% used antidepressants in the 3 months before or after stroke. The adjusted odds ratio (OR) for exposure before and after stroke was 0.92 (95% confidence interval (CI): 0.83-1.01) and 1.19 (95% CI: 1.06-1.31) for poststroke exposure. Tricyclic antidepressant (TCA) or venlafaxine use after stroke was associated with greater odds of a lower ADL score compared to selective serotonin reuptake inhibitors (SSRI). Patients prescribed antidepressants after stroke had increased odds of higher ADL scores, indicating poorer long-term functional status than those who used them before and after stroke or not at all. TCAs and venlafaxine appeared less detrimental to long term function than SSRIs and may be better options for managing poststroke depression.